B4 Capital — 2023 Investments

2 investments dated 2023 · listed companies and verified rows first · show all

Notable Labsnotablelabs.com in 𝕏Mar 2023SEC filingmedium confidence

Notable Labs operates an automated laboratory that tests combinations of existing drugs against individual patients' blood cancer cells to identify effective treatment options for patients whose cancers have become resistant to standard therapies.

BiotechHealthtechMedical DevicesSan Francisco, US

Matthew De Silva(CEO)inPete Quinzio(Founder)inConnor Warnock(Senior Engineer)Van Duesterberg(Science Consultant)Omid Karkouti(Vice President of Business Development)Scott Patterson(Vice President of Engineering)

Board seatAdam Seabrook· per SEC Form D · $10.3M raise · filed Mar 2023

Co-investors11.2 Capital Alumni Ventures Builders VC FundersClub Gaingels Hemisphere Ventures LLC +30 more

Perplexityperplexity.aiMar 2023

An AI-powered answer engine providing accurate, trusted, and real-time answers to questions.

San Francisco, US

Andrew D. Konwinski(Executive Officer, Director)Dzianis Yarats(Director)Aravind Srinivas Lakshminarayanan(Director, Executive Officer)Aravind Srinivas(Founder)inDenis Yarats(Founder)Andrew Konwinski(Founder)

Co-investors1435 Capital 359 Capital 7BC Venture Capital Accel Advaita Capital AIX Ventures +63 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.